Acquired color vision deficiency.
Simunovic MP.
Surv Ophthalmol. 2016 Mar-Apr;61(2):132-55. doi: 10.1016/j.survophthal.2015.11.004. Epub 2015 Nov 30.
Gene Therapy for Color Blindness.
Hassall MM, Barnard AR, MacLaren RE.
Yale J Biol Med. 2017 Dec 19;90(4):543-551. eCollection 2017 Dec.
Achromatopsia: Genetics and Gene Therapy.
Michalakis S, Gerhardt M, Rudolph G, Priglinger S, Priglinger C.
Mol Diagn Ther. 2022 Jan;26(1):51-59. doi: 10.1007/s40291-021-00565-z. Epub 2021 Dec 3.
Rod Monochromatism (Achromatopsia).
Tsang SH, Sharma T.
Adv Exp Med Biol. 2018;1085:119-123. doi: 10.1007/978-3-319-95046-4_24.
Achromatopsia: a review.
Remmer MH, Rastogi N, Ranka MP, Ceisler EJ.
Curr Opin Ophthalmol. 2015 Jul;26(5):333-40. doi: 10.1097/ICU.0000000000000189.
Gene therapy for achromatopsia.
Michalakis S, Schön C, Becirovic E, Biel M.
J Gene Med. 2017 Mar;19(3). doi: 10.1002/jgm.2944.
[Achromatopsia].
Poloschek CM, Kohl S.
Ophthalmologe. 2010 Jun;107(6):571-80; quiz 581-2. doi: 10.1007/s00347-010-2178-8.
Blue Cone Monochromatism.
Tsang SH, Sharma T.
Adv Exp Med Biol. 2018;1085:65-66. doi: 10.1007/978-3-319-95046-4_14.
Gene Therapy for Achromatopsia.
Baxter MF, Borchert GA.
Int J Mol Sci. 2024 Sep 9;25(17):9739. doi: 10.3390/ijms25179739.
Cerebral achromatopsia secondary to ischemic stroke.
Zhou C, He Y, Li X.
Neurol India. 2018 Mar-Apr;66(2):573-575. doi: 10.4103/0028-3886.227322.
